TREATMENT OF SOULIER-BOFFA SYNDROME WITH INTRAVENOUS IMMUNOGLOBULINS - POSSIBLE DISSOCIATION OF CLINICAL AND BIOLOGICAL EFFECTS

被引：1
|
作者：
COSSERAT, J
BLETRY, O
LARAKI, R
HORELLOU, MH
WEILL, B
GODEAU, P
机构：
来源：
REVUE DE MEDECINE INTERNE | 1993年 / 14卷 / 06期
关键词：
D O I：
10.1016/S0248-8663(05)80352-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The treatment of the antiphospholipid syndrome with fetal loss (Soulier-Boffa) is not clearly defined. We have treated 3 women with intravenous-immunoglobulin alone or associated with aspirin, heparin or corticosteroids. All three gave birth to live children. The biological results showed in one case a disappearance of anticardiolipin antibodies, but in two others cases the level of antibodies is still high. These date show that clinical and biological results can be different in Soulier-Boffa syndrome under treatment.
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [31] Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss
    Sapir, T
    Blank, M
    Shoenfeld, Y
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 743 - 778
  • [32] Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IVIg) - Clinical experience to date
    Faye, O
    Roujeau, JC
    DRUGS, 2005, 65 (15) : 2085 - 2090
  • [33] Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg)Clinical Experience to Date
    Ousmane Faye
    Jean-Claude Roujeau
    Drugs, 2005, 65 : 2085 - 2090
  • [34] CLINICAL AND IMMUNOLOGICAL EFFECTS OF COMBINATION THERAPY WITH INTRAVENOUS IMMUNOGLOBULINS AND AZT IN HIV-INFECTED PATIENTS
    DESIMONE, C
    TZANTZOGLOU, S
    SANTINI, G
    VULLO, V
    DIORIO, F
    LEUTER, C
    JIRILLO, E
    DELIA, S
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1991, 13 (03) : 447 - 458
  • [35] Susac syndrome:: Follow-up of visual fields and multifocal electroretinogram after treatment with intravenous immunoglobulins
    Foerl, Birgit
    Krastel, Hermann
    Hartmann, Marius
    Kolling, Gerold
    NEURO-OPHTHALMOLOGY, 2007, 31 (01) : 3 - 6
  • [36] Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins
    Paquet, P
    Jacob, E
    Damas, P
    Piérard, GE
    BURNS, 2001, 27 (06) : 652 - 655
  • [37] Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis
    Luzi, Giuseppe
    Diamanti, Andrea Picchianti
    Germano, Valentina
    Lagana, Bruno
    Di Rosa, Roberta
    Salemi, Simonetta
    Stoppacciaro, Antonella
    D'Amelio, Raffaele
    CLINICAL IMMUNOLOGY, 2007, 125 (02) : 127 - 130
  • [38] Treatment of Guillain-Barre syndrome with intravenous immunoglobulins and methylprednisolone combined with mycophenolate (CellCept®) -: A pilot study
    Garssen, MPJ
    van Koningsveld, R
    van Doorn, PA
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2005, 10 : 24 - 25
  • [39] Clinical, electrophysiological and immunological evaluation of the response to treatment with intravenous immunoglobulins in several immune-mediated neuropathies
    Larrodé-Pellicer, P
    de Sotomayor, FSA
    Iñíguez-Martínez, C
    Santos, S
    Tejero-Juste, C
    Pascual-Millán, LF
    REVISTA DE NEUROLOGIA, 2005, 40 (06) : 345 - 350
  • [40] EFFECTS OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IV IGG) IN SLE PATIENTS WITH VARIOUS CLINICAL MANIFESTATIONS
    HARISDANGKUL, V
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S364 - S364
12345